Dr. Persson previously served as partner in two life science-focused venture capital firms, including on in the San Francisco Bay area. He has experience developing Phase II and Phase III programs in the pharmaceutical industry and has founded private and public biotech and medtech companies.
Dr. Persson has also led recruitment processes for senior management positions.
Related Articles on Spine Devices:
NuVasive Reports 16.2% Increase in 4Q Revenue to $!50.2M
InVivo Hires Former Stryker Leader Brian Hess as Director of Product Development
Synthes Earnings Grow as Johnson & Johnson Acquisition Closing Nears
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.